Study of Abemaciclib in Dedifferentiated Liposarcoma
Clinical trial NCT02846987 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02846987
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2027-07-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.